TCM
Tekla Capital Management’s DexCom DXCM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $29.4M | Hold |
228,747
| – | – | 1.15% | 22 |
|
|
2023
Q1 | $26.6M | Buy |
228,747
+10,732
| +5% | +$1.25M | 1.01% | 30 |
|
|
2022
Q4 | $24.7M | Sell |
218,015
-27,697
| -11% | -$3.14M | 0.93% | 34 |
|
|
2022
Q3 | $19.8M | Buy |
245,712
+115,828
| +89% | +$9.33M | 0.81% | 34 |
|
|
2022
Q2 | $9.68M | Buy |
129,884
+93,213
| +254% | +$6.95M | 0.38% | 63 |
|
|
2022
Q1 | $18.8M | Sell |
36,671
-5,260
| -13% | -$2.69M | 0.66% | 40 |
|
|
2021
Q4 | $22.5M | Sell |
41,931
-1,049
| -2% | -$563K | 0.72% | 40 |
|
|
2021
Q3 | $23.5M | Sell |
42,980
-39,775
| -48% | -$21.8M | 0.76% | 37 |
|
|
2021
Q2 | $35.3M | Buy |
82,755
+8,112
| +11% | +$3.46M | 1.15% | 23 |
|
|
2021
Q1 | $26.8M | Hold |
74,643
| – | – | 0.92% | 26 |
|
|
2020
Q4 | $27.6M | Buy |
74,643
+56,099
| +303% | +$20.7M | 0.97% | 29 |
|
|
2020
Q3 | $7.64M | Buy |
18,544
+11,293
| +156% | +$4.66M | 0.29% | 82 |
|
|
2020
Q2 | $2.94M | Buy |
+7,251
| New | +$2.94M | 0.11% | 141 |
|
|
2018
Q1 | – | Sell |
-53,950
| Closed | -$3.1M | – | 190 |
|
|
2017
Q4 | $3.1M | Sell |
53,950
-53,950
| -50% | -$3.1M | 0.12% | 108 |
|
|
2017
Q3 | $5.28M | Buy |
107,900
+23,400
| +28% | +$1.14M | 0.19% | 86 |
|
|
2017
Q2 | $6.18M | Buy |
84,500
+13,300
| +19% | +$973K | 0.23% | 78 |
|
|
2017
Q1 | $6.03M | Buy |
+71,200
| New | +$6.03M | 0.23% | 78 |
|